NCT01496313 2025-10-03
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
Sanofi
Phase 4 Completed
Clinical Trials
7 trialsNCT02312960 2025-03-25
Radium-223 Dichloride Long-term Follow-up Program
Bayer
Phase 4 Completed
NCT01856023 2023-12-05
PROCLIVITY02
Clinigen, Inc.
Phase 4 Terminated
NCT02441517 2018-04-19
A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment
Astellas Pharma Inc
Phase 4 Terminated
NCT01770431 2017-10-02
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy
Qidong Gaitianli Medicines Co., Ltd
Phase 4 Completed
NCT01961544 2016-10-07
ESKIMO
Eisai Inc.
Phase 4 Completed
NCT00392808 2013-10-11
CSISP-MENC1
Centro Superior de Investigación en Salud Publica
Phase 4 Completed